GNS Board Member Dr. Adrian Weller appointed as Programme Director for Artificial Intelligence at The Alan Turing Institute

February 8, 2018
Today, The Alan Turing Institute announced the appointment of Dr. Adrian Weller as Programme Director for Artificial Intelligence. The Institute,...
Read More

Neo.Life features Iya Khalil in 2018 Biotech Breakthroughs and Big Ideas

January 4, 2018
In this January article, Neo.Life profiles the biggest biotech breakthroughs and big ideas for 2018, including thoughts from Iya Khalil,...
Read More

PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors

January 3, 2018
Pharmaceutical Product Development, LLC (PPD) today announced that Colin Hill has been named to the company’s board of directors. Hill...
Read More

GenomeWeb Features GNS Healthcare’s Novel Parkinson’s Gene Discovery

October 4, 2017
Recently published research powered by GNS Healthcare, maker of a causal machine-learning platform for precision medicine, promises to unravel some of...
Read More

GNS Co-Founders Included on 50+ Most Influential People of Color in Life Sciences & Healthcare

September 21, 2017
GNS co-founders Colin Hill and Dr. Iya Khalil have been included on the list of the 50+ Most Influential People...
Read More

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

August 23, 2017
August 23, 2017 — Xconomy Boston — The investment arm of biotech giant Amgen has led a new $6 million round of funding in GNS...
Read More

BioCentury highlights GNS-Alexion partnership

August 23, 2017
Alexion rebuilding pipeline with big data deals   August 10, 2017 – Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) is rebuilding its early stage...
Read More

FierceBiotech features Alexion-GNS Partnership Targeting Rare Diseases

August 21, 2017
Alexion inks genomics pacts to continue R&D reboot August 11, 2017  – Alexion has teamed up with GNS Healthcare and...
Read More

Rare Disease Report Covers Alexion-GNS REFS Licensing Agreement

August 20, 2017
Rare Disease Treatments to Be Discovered by Machine Learning and Simulation Platform
Read More

Gregg’s Diabetes Identifies GNS as One of a Handful of Companies Focused on Market Access

February 2, 2017
The 21st Century Cures Act makes “Real World Evidence” a buzz word in pharma and payer circles, and justifiably so....
Read More

BioCentury Article Highlights GNS Discoveries on Behalf of The MMRF

December 7, 2016
GNS Healthcare Inc. (Cambridge, Mass.) said it has identified four genes as "top drivers" of high-risk multiple myeloma. Using its machine...
Read More
1 2 3 4